March 16th 2023
Look for fluctuating vision, test objectively and keep a few effective tools at your disposal to treat OSD.
January 20th 2023
2023: What ophthalmologists in Europe anticipate for the year aheadDecember 12th 2022
Members of the Ophthalmology Times Europe® Editorial Advisory Board were asked to predict developments in their ophthalmic specialties and interests for 2023. A focus is our ageing population, while efficiency and productivity are also on their minds. The board members agree that one of the major challenges in the year to come will be the large number of patients awaiting diagnosis and treatment, which is only going to increase with the rising average life expectancy worldwide.
Myth or reality? Corneal refractive surgery to manage presbyopic patientsDecember 6th 2022
A corneal refractive technique can combine monovision and extended depth of field to create a wide, seamless range of functional vision. This can provide independence from spectacles.
Systemic factors not predictive of VA outcomes following cataract surgery in patients with diabetic retinopathyOctober 29th 2022
Investigators evaluated VA outcomes after cataract surgery and the factors associated with good visual outcomes in a population of patients with type 2 diabetes.
Top ophthalmologists anticipate ESCRS sessionsSeptember 15th 2022
Members of the Ophthalmology Times Europe Editorial Advisory Board offer comments on the symposia they are most excited to attend at the 2022 ESCRS Congress in Milan, Italy.
A new lens option for enhanced monovision performanceSeptember 13th 2022
In “modified monovision”, which can be achieved with a new IOL, one eye predominantly manages distance vision and the other near vision—as with standard monovision—but the extended depth of field provides a degree of intermediate vision that is independent of spectacles.
Congress of the ESCRS reaches milestone ageSeptember 12th 2022
Taking place from 16–20 September 2022, and following the success of last year’s congress, the 40th ESCRS will again be a face-to-face event but supported by a virtual conferencing platform that will allow the sessions to also be streamed.
Phase 3 study of CPN-302: Positive topline results for post-cataract surgery drug candidateAugust 13th 2022
The companies note that data from Study CPN-302 confirm the results in the first Phase 3 study, CPN-301, and they demonstrate the clear benefits of treating patients after cataract surgery with APP13007.
Black-and-white filters optimize visualization during cataract surgeryJuly 28th 2022
While the surgeons reported that the BW filter provided higher contrast during nucleus and viscous removal and posterior capsular polishing, they subjectively reported no significant advantage of using a BW filter.
Testing spectacle lenses for myopia control in relation to changes in axial lengthMay 4th 2022
Dr Eva Chamorro points out that myopia control spectacle lenses affect the diurnal rhythms in the AL in young adult human and produced a small short-term increase in the AL that varies in intensity and time interval for each of the 3 studied lenses.